Authors
Randy Dotinga is a medical writer based in San Diego, Calif.
CEO and Co-Founder, Cultura Dermatology and Laser Center, Washington, D.C.
Advertisement
Advertisement
Trending on Dermatology Times
1
Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity
2
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
3
Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026
4
Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS
5
